Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction
机构:[1]Department of Cardiology, Kunming Medical University, The 920th Hospital, Kunming, Yunnan, China.[2]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.[3]Department of Cardiology, 920th Hospital of Joint Logistics Support Force, People's Liberation Army of China (PLA), Kunming, Yunnan, China.[4]Proctology Department of Traditional Chinese Medicine, First People's Hospital of Yunnan Province, Kunming, China.云南省第一人民医院中医(肛肠)科外科片
This study was supported by the Science and Technology
Department of Yunnan Province (202101AY070001-030) and
the 920th Hospital of Joint Logistics Support Force, PLA
(2020YGD11).
第一作者机构:[1]Department of Cardiology, Kunming Medical University, The 920th Hospital, Kunming, Yunnan, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Li Xicong,Lu Lifei,Yuan Qi,et al.Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction[J].FRONTIERS IN CARDIOVASCULAR MEDICINE.2022,9:doi:10.3389/fcvm.2022.991479.
APA:
Li Xicong,Lu Lifei,Yuan Qi,Yang Lixia,Du Liping&Guo Ruiwei.(2022).Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction.FRONTIERS IN CARDIOVASCULAR MEDICINE,9,
MLA:
Li Xicong,et al."Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction".FRONTIERS IN CARDIOVASCULAR MEDICINE 9.(2022)